Gene · 3313
NIH grants1,948
NIH grants whose papers are about the gene, through NIH's grant-paper links.
841 to 860 of 1,948
Download this page as JSON| Grant | Title | HSPA9 papers | Newest fiscal year |
|---|---|---|---|
| R01HL132300 | MCL-1 is a critical regulator of mitochondrial dynamics and function in myocytes | 1 | 2020 |
| R01HL135893 | Harnessing the Adaptive ER Stress Response in Myocardial Ischemia | 1 | 2020 |
| R01HL135901 | Novel Regulatory Mechanisms in the Human Microcirculation | 1 | 2020 |
| R01HL136431 | Macrophage-derived microcalcificaitons | 1 | 2020 |
| R01HL137282 | Perinatal NO signaling in congenital heart disease | 1 | 2020 |
| R01HL137371 | FUNDC1 and diabetic cardiomyopathy | 1 | 2020 |
| R01HL138560 | Role of the Endosomal-Lysosomal Pathway in Mitochondrial Quality Control | 1 | 2020 |
| R01MH096625 | Astrocyte connexin43 containing channels amplify CNS dysfunction in NeuroAIDS | 1 | 2020 |
| R01NS056224 | Deranged calcium signaling and polyglutamine expansion disorders | 1 | 2020 |
| R01NS065013 | Role of Parkin in Familial and Idiopathic Parkinson's Disease | 1 | 2020 |
| R01NS076054 | The Role of Lysosomal Glucocerebrosidase in Synucleinopathies | 1 | 2020 |
| R01NS099125 | Mechanisms of the recognition of degenerating dendrites | 1 | 2020 |
| R03DK116011 | Determining the Mechanism for ApoC-III Stimulation of IL-10 and Tregs in the Intestine: Is this Novel Effect Beneficial? | 1 | 2020 |
| R03HL148483 | Single cell analysis of gene expression in human vascular cells | 1 | 2020 |
| R03TR003308 | Targeting understudied kinases in cancer cell plasticity and drug resistance | 1 | 2020 |
| R21AG061468 | Elucidating the molecular mechanisms of spinocerebellar ataxia gene TMEM16K in interorganellar communication | 1 | 2020 |
| R21AG061697 | Defining the molecular mechanisms underlying mitochondrial proteostasis | 1 | 2020 |
| R21AG064596 | A transcriptomic atlas of immune cells in a model of synucleinopathy | 1 | 2020 |
| R21AR072950 | Quantitative imaging of the dystrophin-glycoprotein complex | 1 | 2020 |
| R21GM132778 | Optogenetic Engineering of 3D Chromatin Architecture | 1 | 2020 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3313/grants?page=43